1 Product identity
Ingredient risk
No flagged ingredients
Blood Sugar Breakthrough
BrandBiOptimizers→Other Combinations Capsule 18 ingredients DSLD #320981Net contents: 60 Veggie Cap(s)
Target: Adults and Children 4 years and above
DSLD entry: 2025-01-23
2 Ingredients (18)
IngredientGroupSafety
Proprietary BlendProprietary Blend—
Irvingia gabonensisIrvingia gabonensis—
NaringinNaringenin—
BenfotiamineBenfotiamine—
Banaba leaf extractbanaba—
FucoxanthinFucoxanthin—
Bitter Melon Fruit ExtractBitter Melon—
Cinnulin PFCinnamomum burmanii—
InnoSlimProprietary Blend (Herb/Botanical)—
HypromelloseHypromellose—
Rice FiberRice Fiber—
Rice Extract BlendRice—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
3 Safety cross-reference
Biotin — Generally Safe
⚠ Interferes with troponin and thyroid lab assays
Chromium — Conditionally Safe
⚠ Hypoglycemia with diabetes meds
⚠ Rare renal/hepatic toxicity
Sea Buckthorn — Generally Safe
⚠ May increase bleeding risk
⚠ May lower blood pressure
Alpha-Lipoic Acid — Limited Evidence
⚠ May lower blood glucose
⚠ May lower thyroid hormones
Gymnema — Conditionally Safe
⚠ Hypoglycemia with diabetes meds
⚠ Temporarily suppresses sweet taste
Berberine — Limited Evidence
⚠ POTENT CYP INHIBITOR — many drug interactions
⚠ Hypoglycemia
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID320981
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2025-01-23
6 More from BiOptimizers
View BiOptimizers Safety Scorecard → 1 products
7 Cite this page
Vancouver
Pkhakadze G. Blood Sugar Breakthrough — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 24]. Available from: https://supplement.ge/products/dsld-320981/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG